Cargando…

Factors affecting patient participation in clinical trials in Ireland: A narrative review

OBJECTIVE: Clinical trials have long been considered the ‘gold standard’ of research generated evidence in health care. Patient recruitment is an important determinant in the success of the trials, yet little focus is placed on the decision making process of patients towards recruitment. Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Elaine, Sheridan, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935836/
https://www.ncbi.nlm.nih.gov/pubmed/29736453
http://dx.doi.org/10.1016/j.conctc.2016.01.002
_version_ 1783320340590493696
author Walsh, Elaine
Sheridan, Ann
author_facet Walsh, Elaine
Sheridan, Ann
author_sort Walsh, Elaine
collection PubMed
description OBJECTIVE: Clinical trials have long been considered the ‘gold standard’ of research generated evidence in health care. Patient recruitment is an important determinant in the success of the trials, yet little focus is placed on the decision making process of patients towards recruitment. Our objective was to identify the key factors pertaining to patient participation in clinical trials, to better understand the identified low participation rate of patients in one clinical research facility within Ireland. DESIGN: Narrative literature review of studies focussing on factors which may act to facilitate or deter patient participation in clinical trials. Studies were identified from Medline, PubMed, Cochrane Library and CINAHL. RESULTS: Sixty-one studies were included in the narrative review: Forty-eight of these papers focused specifically on the patient's perspective of participating in clinical trials. The remaining thirteen related to carers, family and health care professional perspectives of participation. The primary factor influencing participation in clinical trials amongst patients was related to personal factors and these were collectively associated with obtaining a form of personal gain through participation. Cancer was identified as the leading disease entity included in clinical trials followed by HIV and cardiovascular disease. CONCLUSION: The vast majority of literature relating to participation in clinical trials emanates predominantly from high income countries, with 63% originating from the USA. No studies for inclusion in this review were identified from low income or developing countries and therefore limits the generalizability of the influencing factors.
format Online
Article
Text
id pubmed-5935836
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59358362018-05-07 Factors affecting patient participation in clinical trials in Ireland: A narrative review Walsh, Elaine Sheridan, Ann Contemp Clin Trials Commun Article OBJECTIVE: Clinical trials have long been considered the ‘gold standard’ of research generated evidence in health care. Patient recruitment is an important determinant in the success of the trials, yet little focus is placed on the decision making process of patients towards recruitment. Our objective was to identify the key factors pertaining to patient participation in clinical trials, to better understand the identified low participation rate of patients in one clinical research facility within Ireland. DESIGN: Narrative literature review of studies focussing on factors which may act to facilitate or deter patient participation in clinical trials. Studies were identified from Medline, PubMed, Cochrane Library and CINAHL. RESULTS: Sixty-one studies were included in the narrative review: Forty-eight of these papers focused specifically on the patient's perspective of participating in clinical trials. The remaining thirteen related to carers, family and health care professional perspectives of participation. The primary factor influencing participation in clinical trials amongst patients was related to personal factors and these were collectively associated with obtaining a form of personal gain through participation. Cancer was identified as the leading disease entity included in clinical trials followed by HIV and cardiovascular disease. CONCLUSION: The vast majority of literature relating to participation in clinical trials emanates predominantly from high income countries, with 63% originating from the USA. No studies for inclusion in this review were identified from low income or developing countries and therefore limits the generalizability of the influencing factors. Elsevier 2016-03-02 /pmc/articles/PMC5935836/ /pubmed/29736453 http://dx.doi.org/10.1016/j.conctc.2016.01.002 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Walsh, Elaine
Sheridan, Ann
Factors affecting patient participation in clinical trials in Ireland: A narrative review
title Factors affecting patient participation in clinical trials in Ireland: A narrative review
title_full Factors affecting patient participation in clinical trials in Ireland: A narrative review
title_fullStr Factors affecting patient participation in clinical trials in Ireland: A narrative review
title_full_unstemmed Factors affecting patient participation in clinical trials in Ireland: A narrative review
title_short Factors affecting patient participation in clinical trials in Ireland: A narrative review
title_sort factors affecting patient participation in clinical trials in ireland: a narrative review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935836/
https://www.ncbi.nlm.nih.gov/pubmed/29736453
http://dx.doi.org/10.1016/j.conctc.2016.01.002
work_keys_str_mv AT walshelaine factorsaffectingpatientparticipationinclinicaltrialsinirelandanarrativereview
AT sheridanann factorsaffectingpatientparticipationinclinicaltrialsinirelandanarrativereview